Bio-Rad Laboratories, Inc. announced Operating income margin guidance remains at about 19% as they manage operating expense plan for the remainder of this year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
287.2 USD | -1.05% | -2.26% | -11.05% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.05% | 8.16B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.66B | |
+4.91% | 41.3B | |
+21.98% | 31.6B | |
+14.45% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Bio-Rad Laboratories, Inc. Provides Earnings Guidance for the Year 2022